ACTL8 and neoplasm: Only 3 tumor-reactive circulating CD8 T cell lines showed responses, which were limited to two CTA (PLAC1 and ACTL8) overlapping peptide pools, reiterating the challenge of finding relevant breast cancer antigens (Figure 2G).